Clinical Trial Update: Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results for everolimus (RAD001) therapy of giant cell astrocytoma in patients with tuberous sclerosis complex (Phase 1/2; com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subependymal Giant Cell Astrocytoma
• Tuberous Sclerosis Complex

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-20